Advanced Cell concludes an early-stage trial of its myoblast program

09/29/2010 | Mass High Tech (Boston)

Advanced Cell Technology plans to launch a midstage trial of its myoblast therapy during the first half of 2011, after finishing a Phase I study in heart failure patients. The Phase II trial will test the myoblast program, which involves the use of adult progenitor stem cells derived from a biopsy of skeletal muscle, in patients who are not fit to undergo bypass surgery or angioplasty.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC